nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—XDH—Effects of Nitric Oxide—HBA1—type 2 diabetes mellitus	0.0207	0.102	CbGpPWpGaD
Deferoxamine—XDH—Effects of Nitric Oxide—NOS1—type 2 diabetes mellitus	0.0165	0.0818	CbGpPWpGaD
Deferoxamine—XDH—Purine catabolism—CAT—type 2 diabetes mellitus	0.0114	0.0563	CbGpPWpGaD
Deferoxamine—XDH—Purine catabolism—GPX1—type 2 diabetes mellitus	0.0103	0.051	CbGpPWpGaD
Deferoxamine—XDH—Effects of Nitric Oxide—NOS2—type 2 diabetes mellitus	0.00986	0.0488	CbGpPWpGaD
Deferoxamine—XDH—Effects of Nitric Oxide—NOS3—type 2 diabetes mellitus	0.00793	0.0392	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—AK1—type 2 diabetes mellitus	0.00733	0.0363	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—CYBA—type 2 diabetes mellitus	0.00624	0.0309	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—SOD1—type 2 diabetes mellitus	0.00498	0.0246	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—CBS—type 2 diabetes mellitus	0.00484	0.0239	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—HMOX1—type 2 diabetes mellitus	0.00479	0.0237	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—CAT—type 2 diabetes mellitus	0.00473	0.0234	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—SOD2—type 2 diabetes mellitus	0.00448	0.0222	CbGpPWpGaD
Deferoxamine—XDH—Purine metabolism—CAT—type 2 diabetes mellitus	0.00438	0.0217	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—GPX1—type 2 diabetes mellitus	0.00428	0.0212	CbGpPWpGaD
Deferoxamine—XDH—Purine metabolism—GPX1—type 2 diabetes mellitus	0.00396	0.0196	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—MTR—type 2 diabetes mellitus	0.00312	0.0154	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—HBA1—type 2 diabetes mellitus	0.00304	0.015	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—INSR—type 2 diabetes mellitus	0.003	0.0148	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—F7—type 2 diabetes mellitus	0.0029	0.0143	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—PLAT—type 2 diabetes mellitus	0.00258	0.0128	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—CAT—type 2 diabetes mellitus	0.0022	0.0109	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—NFKB1—type 2 diabetes mellitus	0.00219	0.0108	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—SOD1—type 2 diabetes mellitus	0.00211	0.0104	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—CAT—type 2 diabetes mellitus	0.002	0.00989	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—GPX1—type 2 diabetes mellitus	0.00199	0.00985	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—APOB—type 2 diabetes mellitus	0.00194	0.0096	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—SOD2—type 2 diabetes mellitus	0.0019	0.00938	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—GPX1—type 2 diabetes mellitus	0.00181	0.00895	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—MTHFR—type 2 diabetes mellitus	0.00167	0.00826	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—CRP—type 2 diabetes mellitus	0.00159	0.00785	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—APOA1—type 2 diabetes mellitus	0.00154	0.0076	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—ICAM1—type 2 diabetes mellitus	0.00146	0.00722	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—INS—type 2 diabetes mellitus	0.00133	0.00657	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—CCL2—type 2 diabetes mellitus	0.00131	0.00646	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—SERPINE1—type 2 diabetes mellitus	0.00122	0.00603	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—ALB—type 2 diabetes mellitus	0.00122	0.00602	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—RELA—type 2 diabetes mellitus	0.0011	0.00542	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—PTGS2—type 2 diabetes mellitus	0.00106	0.00527	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	0.000924	0.00457	CbGpPWpGaD
Deferoxamine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000848	0.00106	CcSEcCtD
Deferoxamine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000846	0.00106	CcSEcCtD
Deferoxamine—XDH—Metabolism—BHMT—type 2 diabetes mellitus	0.000842	0.00417	CbGpPWpGaD
Deferoxamine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000842	0.00105	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.00084	0.00105	CcSEcCtD
Deferoxamine—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000835	0.00105	CcSEcCtD
Deferoxamine—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000831	0.00104	CcSEcCtD
Deferoxamine—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000829	0.00104	CcSEcCtD
Deferoxamine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000828	0.00104	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000825	0.00103	CcSEcCtD
Deferoxamine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000824	0.00103	CcSEcCtD
Deferoxamine—Infection—Gliclazide—type 2 diabetes mellitus	0.000823	0.00103	CcSEcCtD
Deferoxamine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000822	0.00103	CcSEcCtD
Deferoxamine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000822	0.00103	CcSEcCtD
Deferoxamine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000821	0.00103	CcSEcCtD
Deferoxamine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00082	0.00103	CcSEcCtD
Deferoxamine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000816	0.00102	CcSEcCtD
Deferoxamine—Renal failure—Ramipril—type 2 diabetes mellitus	0.000813	0.00102	CcSEcCtD
Deferoxamine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000813	0.00102	CcSEcCtD
Deferoxamine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000812	0.00102	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000811	0.00102	CcSEcCtD
Deferoxamine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000811	0.00102	CcSEcCtD
Deferoxamine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000808	0.00101	CcSEcCtD
Deferoxamine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000807	0.00101	CcSEcCtD
Deferoxamine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000804	0.00101	CcSEcCtD
Deferoxamine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000801	0.001	CcSEcCtD
Deferoxamine—Erythema—Irbesartan—type 2 diabetes mellitus	0.000801	0.001	CcSEcCtD
Deferoxamine—Vision blurred—Metformin—type 2 diabetes mellitus	0.0008	0.001	CcSEcCtD
Deferoxamine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000798	0.001	CcSEcCtD
Deferoxamine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000797	0.000999	CcSEcCtD
Deferoxamine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000797	0.000999	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000796	0.000998	CcSEcCtD
Deferoxamine—Myalgia—Valsartan—type 2 diabetes mellitus	0.000794	0.000995	CcSEcCtD
Deferoxamine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000794	0.000995	CcSEcCtD
Deferoxamine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000792	0.000993	CcSEcCtD
Deferoxamine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000791	0.000992	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000788	0.000988	CcSEcCtD
Deferoxamine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000786	0.000985	CcSEcCtD
Deferoxamine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000785	0.000984	CcSEcCtD
Deferoxamine—Myalgia—Orlistat—type 2 diabetes mellitus	0.000784	0.000983	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000779	0.000976	CcSEcCtD
Deferoxamine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000774	0.00097	CcSEcCtD
Deferoxamine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000774	0.00097	CcSEcCtD
Deferoxamine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.00077	0.000965	CcSEcCtD
Deferoxamine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000765	0.000959	CcSEcCtD
Deferoxamine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000763	0.000956	CcSEcCtD
Deferoxamine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000762	0.000955	CcSEcCtD
Deferoxamine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000761	0.000954	CcSEcCtD
Deferoxamine—Oedema—Valsartan—type 2 diabetes mellitus	0.000761	0.000954	CcSEcCtD
Deferoxamine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000759	0.000951	CcSEcCtD
Deferoxamine—Infection—Valsartan—type 2 diabetes mellitus	0.000756	0.000947	CcSEcCtD
Deferoxamine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000755	0.000946	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000754	0.000946	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000754	0.000945	CcSEcCtD
Deferoxamine—Erythema—Losartan—type 2 diabetes mellitus	0.000754	0.000945	CcSEcCtD
Deferoxamine—Oedema—Orlistat—type 2 diabetes mellitus	0.000752	0.000942	CcSEcCtD
Deferoxamine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000752	0.000942	CcSEcCtD
Deferoxamine—Headache—Glipizide—type 2 diabetes mellitus	0.000751	0.000941	CcSEcCtD
Deferoxamine—Shock—Valsartan—type 2 diabetes mellitus	0.000748	0.000938	CcSEcCtD
Deferoxamine—Infection—Orlistat—type 2 diabetes mellitus	0.000747	0.000936	CcSEcCtD
Deferoxamine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000746	0.000935	CcSEcCtD
Deferoxamine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000745	0.000934	CcSEcCtD
Deferoxamine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000744	0.000932	CcSEcCtD
Deferoxamine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000739	0.000927	CcSEcCtD
Deferoxamine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000739	0.000926	CcSEcCtD
Deferoxamine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000738	0.000925	CcSEcCtD
Deferoxamine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000737	0.000924	CcSEcCtD
Deferoxamine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000737	0.000924	CcSEcCtD
Deferoxamine—XDH—Metabolism—AANAT—type 2 diabetes mellitus	0.000736	0.00364	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PTGDS—type 2 diabetes mellitus	0.000736	0.00364	CbGpPWpGaD
Deferoxamine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000733	0.000918	CcSEcCtD
Deferoxamine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000732	0.000917	CcSEcCtD
Deferoxamine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00073	0.000915	CcSEcCtD
Deferoxamine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.00073	0.000915	CcSEcCtD
Deferoxamine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000729	0.000914	CcSEcCtD
Deferoxamine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000725	0.000908	CcSEcCtD
Deferoxamine—Myalgia—Metformin—type 2 diabetes mellitus	0.000723	0.000906	CcSEcCtD
Deferoxamine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000719	0.000901	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	0.000719	0.00356	CbGpPWpGaD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000718	0.0009	CcSEcCtD
Deferoxamine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000717	0.000899	CcSEcCtD
Deferoxamine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000716	0.000897	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000715	0.000896	CcSEcCtD
Deferoxamine—Nausea—Glipizide—type 2 diabetes mellitus	0.000712	0.000892	CcSEcCtD
Deferoxamine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000711	0.000891	CcSEcCtD
Deferoxamine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000711	0.000891	CcSEcCtD
Deferoxamine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000711	0.000891	CcSEcCtD
Deferoxamine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000709	0.000888	CcSEcCtD
Deferoxamine—Pain—Gliclazide—type 2 diabetes mellitus	0.000708	0.000888	CcSEcCtD
Deferoxamine—Headache—Glimepiride—type 2 diabetes mellitus	0.000701	0.000878	CcSEcCtD
Deferoxamine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000698	0.000875	CcSEcCtD
Deferoxamine—XDH—Metabolism—GPD2—type 2 diabetes mellitus	0.000698	0.00345	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CDO1—type 2 diabetes mellitus	0.000698	0.00345	CbGpPWpGaD
Deferoxamine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000693	0.000869	CcSEcCtD
Deferoxamine—Oedema—Metformin—type 2 diabetes mellitus	0.000693	0.000868	CcSEcCtD
Deferoxamine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000692	0.000868	CcSEcCtD
Deferoxamine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00069	0.000865	CcSEcCtD
Deferoxamine—Angioedema—Losartan—type 2 diabetes mellitus	0.000689	0.000863	CcSEcCtD
Deferoxamine—Infection—Metformin—type 2 diabetes mellitus	0.000688	0.000863	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000685	0.000858	CcSEcCtD
Deferoxamine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000683	0.000856	CcSEcCtD
Deferoxamine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000682	0.000855	CcSEcCtD
Deferoxamine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000682	0.000855	CcSEcCtD
Deferoxamine—Shock—Metformin—type 2 diabetes mellitus	0.000682	0.000854	CcSEcCtD
Deferoxamine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000679	0.000852	CcSEcCtD
Deferoxamine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000679	0.000852	CcSEcCtD
Deferoxamine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000678	0.00085	CcSEcCtD
Deferoxamine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000678	0.00085	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000677	0.000849	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000677	0.000849	CcSEcCtD
Deferoxamine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000675	0.000846	CcSEcCtD
Deferoxamine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000675	0.000846	CcSEcCtD
Deferoxamine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000673	0.000843	CcSEcCtD
Deferoxamine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000671	0.000841	CcSEcCtD
Deferoxamine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000669	0.000839	CcSEcCtD
Deferoxamine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000667	0.000836	CcSEcCtD
Deferoxamine—XDH—Metabolism—AK1—type 2 diabetes mellitus	0.000666	0.00329	CbGpPWpGaD
Deferoxamine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000664	0.000832	CcSEcCtD
Deferoxamine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000663	0.000831	CcSEcCtD
Deferoxamine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000662	0.00083	CcSEcCtD
Deferoxamine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000658	0.000824	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000657	0.000823	CcSEcCtD
Deferoxamine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000655	0.00082	CcSEcCtD
Deferoxamine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000655	0.00082	CcSEcCtD
Deferoxamine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000654	0.000819	CcSEcCtD
Deferoxamine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000654	0.000819	CcSEcCtD
Deferoxamine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000652	0.000818	CcSEcCtD
Deferoxamine—Infection—Irbesartan—type 2 diabetes mellitus	0.00065	0.000814	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000649	0.000813	CcSEcCtD
Deferoxamine—Hypotension—Metformin—type 2 diabetes mellitus	0.000647	0.000811	CcSEcCtD
Deferoxamine—Erythema—Ramipril—type 2 diabetes mellitus	0.000646	0.00081	CcSEcCtD
Deferoxamine—Shock—Irbesartan—type 2 diabetes mellitus	0.000643	0.000806	CcSEcCtD
Deferoxamine—Pain—Orlistat—type 2 diabetes mellitus	0.000643	0.000806	CcSEcCtD
Deferoxamine—Myalgia—Losartan—type 2 diabetes mellitus	0.000642	0.000804	CcSEcCtD
Deferoxamine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000642	0.000804	CcSEcCtD
Deferoxamine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000641	0.000804	CcSEcCtD
Deferoxamine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000641	0.000804	CcSEcCtD
Deferoxamine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00064	0.000802	CcSEcCtD
Deferoxamine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000638	0.0008	CcSEcCtD
Deferoxamine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000635	0.000796	CcSEcCtD
Deferoxamine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000632	0.000792	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000631	0.000791	CcSEcCtD
Deferoxamine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000631	0.000791	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000622	0.00078	CcSEcCtD
Deferoxamine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000622	0.00078	CcSEcCtD
Deferoxamine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000622	0.000779	CcSEcCtD
Deferoxamine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000618	0.000774	CcSEcCtD
Deferoxamine—Oedema—Losartan—type 2 diabetes mellitus	0.000615	0.000771	CcSEcCtD
Deferoxamine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000615	0.000771	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000615	0.00077	CcSEcCtD
Deferoxamine—XDH—Metabolism—MAT1A—type 2 diabetes mellitus	0.000615	0.00304	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000615	0.00304	CbGpPWpGaD
Deferoxamine—Infection—Losartan—type 2 diabetes mellitus	0.000611	0.000766	CcSEcCtD
Deferoxamine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000611	0.000766	CcSEcCtD
Deferoxamine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00061	0.000765	CcSEcCtD
Deferoxamine—Shock—Losartan—type 2 diabetes mellitus	0.000605	0.000759	CcSEcCtD
Deferoxamine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000604	0.000758	CcSEcCtD
Deferoxamine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000603	0.000756	CcSEcCtD
Deferoxamine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000602	0.000755	CcSEcCtD
Deferoxamine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000601	0.000754	CcSEcCtD
Deferoxamine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000601	0.000753	CcSEcCtD
Deferoxamine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000599	0.000751	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000598	0.00075	CcSEcCtD
Deferoxamine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000597	0.000749	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000596	0.000747	CcSEcCtD
Deferoxamine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000594	0.000745	CcSEcCtD
Deferoxamine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000594	0.000745	CcSEcCtD
Deferoxamine—XDH—Metabolism—HBA2—type 2 diabetes mellitus	0.000594	0.00294	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ND1—type 2 diabetes mellitus	0.000594	0.00294	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ENPP1—type 2 diabetes mellitus	0.000594	0.00294	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—G6PC—type 2 diabetes mellitus	0.000594	0.00294	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000594	0.00294	CbGpPWpGaD
Deferoxamine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000591	0.00074	CcSEcCtD
Deferoxamine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000587	0.000736	CcSEcCtD
Deferoxamine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000586	0.000735	CcSEcCtD
Deferoxamine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000586	0.000734	CcSEcCtD
Deferoxamine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000583	0.000731	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	0.00058	0.00287	CbGpPWpGaD
Deferoxamine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000579	0.000725	CcSEcCtD
Deferoxamine—Headache—Glyburide—type 2 diabetes mellitus	0.000578	0.000724	CcSEcCtD
Deferoxamine—Hypotension—Losartan—type 2 diabetes mellitus	0.000575	0.000721	CcSEcCtD
Deferoxamine—XDH—Metabolism—GCGR—type 2 diabetes mellitus	0.000575	0.00284	CbGpPWpGaD
Deferoxamine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000567	0.00071	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000567	0.00071	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000564	0.000707	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000561	0.000703	CcSEcCtD
Deferoxamine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000561	0.000703	CcSEcCtD
Deferoxamine—Convulsion—Ramipril—type 2 diabetes mellitus	0.00056	0.000702	CcSEcCtD
Deferoxamine—Pain—Irbesartan—type 2 diabetes mellitus	0.000559	0.000701	CcSEcCtD
Deferoxamine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000554	0.000694	CcSEcCtD
Deferoxamine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000553	0.000692	CcSEcCtD
Deferoxamine—Urticaria—Metformin—type 2 diabetes mellitus	0.00055	0.00069	CcSEcCtD
Deferoxamine—Myalgia—Ramipril—type 2 diabetes mellitus	0.00055	0.00069	CcSEcCtD
Deferoxamine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.00055	0.00069	CcSEcCtD
Deferoxamine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000549	0.000688	CcSEcCtD
Deferoxamine—Nausea—Glyburide—type 2 diabetes mellitus	0.000548	0.000687	CcSEcCtD
Deferoxamine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000548	0.000686	CcSEcCtD
Deferoxamine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000548	0.000686	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000547	0.000685	CcSEcCtD
Deferoxamine—XDH—Metabolism—CYTB—type 2 diabetes mellitus	0.000543	0.00269	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—OXCT1—type 2 diabetes mellitus	0.000543	0.00269	CbGpPWpGaD
Deferoxamine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000538	0.000675	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000535	0.00067	CcSEcCtD
Deferoxamine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000532	0.000667	CcSEcCtD
Deferoxamine—XDH—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000529	0.00262	CbGpPWpGaD
Deferoxamine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000528	0.000661	CcSEcCtD
Deferoxamine—Oedema—Ramipril—type 2 diabetes mellitus	0.000528	0.000661	CcSEcCtD
Deferoxamine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000526	0.00066	CcSEcCtD
Deferoxamine—Pain—Losartan—type 2 diabetes mellitus	0.000526	0.000659	CcSEcCtD
Deferoxamine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000521	0.000652	CcSEcCtD
Deferoxamine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000519	0.000651	CcSEcCtD
Deferoxamine—Shock—Ramipril—type 2 diabetes mellitus	0.000519	0.000651	CcSEcCtD
Deferoxamine—Headache—Gliclazide—type 2 diabetes mellitus	0.000519	0.00065	CcSEcCtD
Deferoxamine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000517	0.000648	CcSEcCtD
Deferoxamine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000517	0.000648	CcSEcCtD
Deferoxamine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000517	0.000648	CcSEcCtD
Deferoxamine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000517	0.000647	CcSEcCtD
Deferoxamine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000515	0.000645	CcSEcCtD
Deferoxamine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000514	0.000645	CcSEcCtD
Deferoxamine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000512	0.000642	CcSEcCtD
Deferoxamine—XDH—Metabolism—ACACA—type 2 diabetes mellitus	0.000505	0.0025	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—STAR—type 2 diabetes mellitus	0.000505	0.0025	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000505	0.0025	CbGpPWpGaD
Deferoxamine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000503	0.000631	CcSEcCtD
Deferoxamine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000503	0.000631	CcSEcCtD
Deferoxamine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000497	0.000623	CcSEcCtD
Deferoxamine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000493	0.000618	CcSEcCtD
Deferoxamine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000492	0.000616	CcSEcCtD
Deferoxamine—Pruritus—Metformin—type 2 diabetes mellitus	0.00049	0.000614	CcSEcCtD
Deferoxamine—Urticaria—Losartan—type 2 diabetes mellitus	0.000489	0.000613	CcSEcCtD
Deferoxamine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000486	0.00061	CcSEcCtD
Deferoxamine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000486	0.00061	CcSEcCtD
Deferoxamine—XDH—Metabolism—ABCC8—type 2 diabetes mellitus	0.000484	0.00239	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CBS—type 2 diabetes mellitus	0.000484	0.00239	CbGpPWpGaD
Deferoxamine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000484	0.000606	CcSEcCtD
Deferoxamine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000482	0.000604	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000481	0.000602	CcSEcCtD
Deferoxamine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000478	0.000599	CcSEcCtD
Deferoxamine—Headache—Valsartan—type 2 diabetes mellitus	0.000477	0.000597	CcSEcCtD
Deferoxamine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000474	0.000594	CcSEcCtD
Deferoxamine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000474	0.000594	CcSEcCtD
Deferoxamine—Headache—Orlistat—type 2 diabetes mellitus	0.000471	0.00059	CcSEcCtD
Deferoxamine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00047	0.00059	CcSEcCtD
Deferoxamine—XDH—Metabolism—COX2—type 2 diabetes mellitus	0.000466	0.0023	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000466	0.0023	CbGpPWpGaD
Deferoxamine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000463	0.00058	CcSEcCtD
Deferoxamine—Dizziness—Metformin—type 2 diabetes mellitus	0.000458	0.000574	CcSEcCtD
Deferoxamine—XDH—Metabolism—NCOA6—type 2 diabetes mellitus	0.000458	0.00226	CbGpPWpGaD
Deferoxamine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000455	0.000571	CcSEcCtD
Deferoxamine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000453	0.000568	CcSEcCtD
Deferoxamine—Nausea—Valsartan—type 2 diabetes mellitus	0.000452	0.000566	CcSEcCtD
Deferoxamine—XDH—Metabolism—UCP2—type 2 diabetes mellitus	0.00045	0.00223	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—UCP3—type 2 diabetes mellitus	0.00045	0.00223	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HSD11B1—type 2 diabetes mellitus	0.00045	0.00223	CbGpPWpGaD
Deferoxamine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000447	0.000561	CcSEcCtD
Deferoxamine—Nausea—Orlistat—type 2 diabetes mellitus	0.000447	0.00056	CcSEcCtD
Deferoxamine—Vomiting—Metformin—type 2 diabetes mellitus	0.00044	0.000552	CcSEcCtD
Deferoxamine—Pruritus—Losartan—type 2 diabetes mellitus	0.000435	0.000546	CcSEcCtD
Deferoxamine—Headache—Metformin—type 2 diabetes mellitus	0.000434	0.000544	CcSEcCtD
Deferoxamine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000432	0.000542	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000431	0.000541	CcSEcCtD
Deferoxamine—XDH—Metabolism—PCK1—type 2 diabetes mellitus	0.000423	0.00209	CbGpPWpGaD
Deferoxamine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000421	0.000528	CcSEcCtD
Deferoxamine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000419	0.000525	CcSEcCtD
Deferoxamine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000417	0.000523	CcSEcCtD
Deferoxamine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000417	0.000523	CcSEcCtD
Deferoxamine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000416	0.000521	CcSEcCtD
Deferoxamine—Nausea—Metformin—type 2 diabetes mellitus	0.000412	0.000516	CcSEcCtD
Deferoxamine—Headache—Irbesartan—type 2 diabetes mellitus	0.00041	0.000513	CcSEcCtD
Deferoxamine—Dizziness—Losartan—type 2 diabetes mellitus	0.000407	0.00051	CcSEcCtD
Deferoxamine—XDH—Metabolism—HK1—type 2 diabetes mellitus	0.000396	0.00196	CbGpPWpGaD
Deferoxamine—Vomiting—Losartan—type 2 diabetes mellitus	0.000391	0.00049	CcSEcCtD
Deferoxamine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000389	0.000487	CcSEcCtD
Deferoxamine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000388	0.000487	CcSEcCtD
Deferoxamine—Headache—Losartan—type 2 diabetes mellitus	0.000385	0.000483	CcSEcCtD
Deferoxamine—XDH—Metabolism—GCKR—type 2 diabetes mellitus	0.000382	0.00189	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000382	0.00189	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000382	0.00189	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—LPA—type 2 diabetes mellitus	0.000382	0.00189	CbGpPWpGaD
Deferoxamine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000373	0.000468	CcSEcCtD
Deferoxamine—XDH—Metabolism—ALDOB—type 2 diabetes mellitus	0.000367	0.00181	CbGpPWpGaD
Deferoxamine—Nausea—Losartan—type 2 diabetes mellitus	0.000365	0.000458	CcSEcCtD
Deferoxamine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000361	0.000452	CcSEcCtD
Deferoxamine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000349	0.000437	CcSEcCtD
Deferoxamine—XDH—Metabolism—GLP1R—type 2 diabetes mellitus	0.000341	0.00169	CbGpPWpGaD
Deferoxamine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000335	0.00042	CcSEcCtD
Deferoxamine—Headache—Ramipril—type 2 diabetes mellitus	0.000331	0.000414	CcSEcCtD
Deferoxamine—XDH—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000318	0.00157	CbGpPWpGaD
Deferoxamine—Nausea—Ramipril—type 2 diabetes mellitus	0.000313	0.000393	CcSEcCtD
Deferoxamine—XDH—Metabolism—MTR—type 2 diabetes mellitus	0.000312	0.00154	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CPT1A—type 2 diabetes mellitus	0.000312	0.00154	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—NAMPT—type 2 diabetes mellitus	0.000306	0.00151	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HBA1—type 2 diabetes mellitus	0.000304	0.0015	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—LIPC—type 2 diabetes mellitus	0.000304	0.0015	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GCK—type 2 diabetes mellitus	0.000304	0.0015	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000302	0.00149	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000297	0.00147	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CETP—type 2 diabetes mellitus	0.000293	0.00145	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SNAP25—type 2 diabetes mellitus	0.000273	0.00135	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PSMD6—type 2 diabetes mellitus	0.000273	0.00135	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SREBF1—type 2 diabetes mellitus	0.000273	0.00135	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CTGF—type 2 diabetes mellitus	0.000268	0.00132	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HMGCR—type 2 diabetes mellitus	0.000265	0.00131	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000259	0.00128	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000249	0.00123	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000246	0.00122	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000246	0.00122	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CYP3A4—type 2 diabetes mellitus	0.00024	0.00119	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GCG—type 2 diabetes mellitus	0.000236	0.00117	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000236	0.00117	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GNB3—type 2 diabetes mellitus	0.000204	0.00101	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000204	0.00101	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HMOX1—type 2 diabetes mellitus	0.000203	0.001	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CAT—type 2 diabetes mellitus	0.0002	0.00099	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOB—type 2 diabetes mellitus	0.000194	0.000961	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GSTM1—type 2 diabetes mellitus	0.000189	0.000935	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—LPL—type 2 diabetes mellitus	0.000185	0.000917	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ADCY5—type 2 diabetes mellitus	0.000182	0.000898	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GPX1—type 2 diabetes mellitus	0.000181	0.000895	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CD36—type 2 diabetes mellitus	0.000176	0.000872	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000174	0.000861	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—MTHFR—type 2 diabetes mellitus	0.000167	0.000826	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPARA—type 2 diabetes mellitus	0.000164	0.00081	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—AGT—type 2 diabetes mellitus	0.000159	0.000785	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CALM1—type 2 diabetes mellitus	0.000156	0.000772	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOE—type 2 diabetes mellitus	0.000155	0.000769	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOA1—type 2 diabetes mellitus	0.000154	0.00076	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPARG—type 2 diabetes mellitus	0.000135	0.00067	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—INS—type 2 diabetes mellitus	0.000133	0.000657	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ALB—type 2 diabetes mellitus	0.000122	0.000602	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—NOS3—type 2 diabetes mellitus	0.000116	0.000576	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PIK3R1—type 2 diabetes mellitus	0.000116	0.000576	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PTGS2—type 2 diabetes mellitus	0.000106	0.000527	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—AKT1—type 2 diabetes mellitus	5.35e-05	0.000265	CbGpPWpGaD
